A DNA immunogen encoding a bivalent tumor Id and an anti-MHC class II scFv antibody was able to induce in mice higher levels of anti-Id antibodies than in control animals that had received an unrelated targeting unit or in animals not expressing the specific class II allele. This evidence concerns the gene ID1 and neoplasm.